Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys

statnews.com/2025/06/18/sarepta-duchenne-muscular-dystrophy-elevidys-death-fda-advocacy

On Sunday at 1 a.m. Eastern time, an announcement went out from the first-generation gene therapy company for Duchenne muscular dystrophy: A second patient who had been treated with Elevidys has died.
This second family said yes to hope, yes to science, yes to the risk, and is now…

This story appeared on statnews.com, 2025-06-19 07:44:37.786000.
The Entire Business World on a Single Page. Free to Use →